United-Guardian Q1 2025 Earnings: Revenue Down 24%, EPS Falls to $0.12
PorAinvest
sábado, 10 de mayo de 2025, 8:17 am ET1 min de lectura
ASH--
The decrease in earnings was primarily attributed to a significant drop in cosmetic ingredients sales, which declined by 63% due to reduced orders from Ashland Specialty Ingredients (ASI) caused by excess inventory in China. However, the company noted positive developments in other segments, with medical lubricant sales increasing by 43% and pharmaceutical sales growing by 23% [2].
The company's earnings per share (EPS) fell from $0.20 in Q1 2024 to $0.12 in Q1 2025. The profit margin also declined from 28% in Q1 2024 to 23% in Q1 2025, primarily due to the revenue decrease [3].
President Donna Vigilante stated, "We are experiencing a slow start to 2025 compared to the beginning of 2024. While we saw positive performance from our medical lubricant and pharmaceutical businesses, the main reason for the decrease in sales and earnings was due to a decrease in our cosmetic ingredient business." She also expressed concerns about potential impacts from U.S. tariffs on imports from various countries [2].
United-Guardian is a manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients. The company's stock is listed on the NASDAQ under the ticker symbol UG.
References:
[1] https://www.rttnews.com/3537321/united-guardian-inc-q1-profit-declines.aspx
[2] https://www.stocktitan.net/news/UG/united-guardian-reports-first-quarter-v17dogk8xu19.html
[3] https://www.marketscreener.com/quote/stock/UNITED-GUARDIAN-INC-5138979/news/United-Guardian-Inc-Reports-Earnings-Results-for-the-First-Quarter-Ended-March-31-2025-49880992/
UG--
United-Guardian reported Q1 2025 earnings with revenue down 24% to $2.48m, net income down 39% to $560.9k, and EPS down to $0.12 from $0.20 in Q1 2024. The decrease in profit margin was driven by lower revenue, down to 23% from 28% in Q1 2024.
United-Guardian Inc. (UG) reported its first-quarter 2025 earnings, showing a substantial decline in financial performance. The company's revenue fell by 23.8% to $2.481 billion from $3.254 billion in the same period last year. Net income decreased by 39.4% to $560.89 million, or $0.12 per share, from $925.44 million, or $0.20 per share, in Q1 2024 [1][2].The decrease in earnings was primarily attributed to a significant drop in cosmetic ingredients sales, which declined by 63% due to reduced orders from Ashland Specialty Ingredients (ASI) caused by excess inventory in China. However, the company noted positive developments in other segments, with medical lubricant sales increasing by 43% and pharmaceutical sales growing by 23% [2].
The company's earnings per share (EPS) fell from $0.20 in Q1 2024 to $0.12 in Q1 2025. The profit margin also declined from 28% in Q1 2024 to 23% in Q1 2025, primarily due to the revenue decrease [3].
President Donna Vigilante stated, "We are experiencing a slow start to 2025 compared to the beginning of 2024. While we saw positive performance from our medical lubricant and pharmaceutical businesses, the main reason for the decrease in sales and earnings was due to a decrease in our cosmetic ingredient business." She also expressed concerns about potential impacts from U.S. tariffs on imports from various countries [2].
United-Guardian is a manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients. The company's stock is listed on the NASDAQ under the ticker symbol UG.
References:
[1] https://www.rttnews.com/3537321/united-guardian-inc-q1-profit-declines.aspx
[2] https://www.stocktitan.net/news/UG/united-guardian-reports-first-quarter-v17dogk8xu19.html
[3] https://www.marketscreener.com/quote/stock/UNITED-GUARDIAN-INC-5138979/news/United-Guardian-Inc-Reports-Earnings-Results-for-the-First-Quarter-Ended-March-31-2025-49880992/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios